Supporting Methods

Immunization of rabbits with V3 peptides
The 34-residue V3 peptides were derived from the sequences of CC1/85 or CC101.19. V3-CC1/85 and V3-CC101.19 peptides have the same sequences as the ones represented in Fig.1C , but lack the N-terminal cysteine residue. The peptides were synthesized, HPLC-purified and conjugated to KLH by Pocono Rabbit Farm and Laboratory (Canadensis, PA).
Specific pathogen free (SPF) New Zealand White female rabbits were immunized intradermally with 200 µg of the KLH-conjugated peptides on day 0, using complete Freund's adjuvant and a proprietary Immune Stimulator according to the Quick Draw Rabbit Polyclonal Antibody Protocol (Pocono Rabbit Farm and Laboratory). Rabbits R1 and R2 received the V3-CC1/85 peptide, R3 and R4 V3-CC101.19. Booster immunizations with 100 µg of the KLH-conjugated peptides in incomplete Freund's adjuvant were administered subcutaneously on days 7, 14 and 35. Blood was collected prior to immunization and on days 21, 28, 35, 42, 49 and 52.
V3 peptide ELISA
In brief, 100 µl of each V3 peptide (1 µg/ml) were coated onto microplate wells (Immulux HB, Dynex, Chantilly, VA) overnight at 4°C in sodium carbonate buffer. The plates were washed with PBS/0.1% Tween, and then blocked with PBS/10% FBS for 2h. Serum samples were serially diluted in blocking buffer and added to the wells for 1h at room temperature. After washing with PBS/0.1% Tween, an HRP-conjugated anti-rabbitIgG + IgM detection antibody (SouthernBiotech, AL) was added for 1h at RT. After washing with PBS/0.1% Tween, the colorimetric endpoint was determined at 490nm using the AMPAK system according to the manufacturer's recommendation (OXOID, Cambridgeshire, UK). For each serum dilution, the OD 490 value derived using preimmune serum was subtracted from the value derived using test serum.
Non-linear sigmoidal dose-response curves were generated with Prism software. End-point titers were calculated as follows: X = logEC 50 -([log(TOP/Y-1)/Hillslope]), where Y = 5 SD of 3 background wells receiving V3 peptides but no serum and X = log[serum dilution] (the logEC 50 , TOP and Hillslope parameters were calculated using Graphpad Prism software). Midpoint titers (EC 50 values) were calculated using Prism.
gp120 capture ELISA
The procedure was identical to that outlined in the main text, except that rabbit immune or pre-immune sera diluted in TSM were used, and the HRP-labeled detection antibody was specific for rabbit antibodies.
